Moloney Securities Asset Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$223K Buy
12,080
+390
+3% +$6.37K 0.03% 424
2025
Q2
$181K Sell
11,690
-4,634
-28% -$71.8K 0.02% 448
2025
Q1
$265K Buy
16,324
+5,379
+49% +$92.5K 0.04% 382
2024
Q4
$176K Buy
10,945
+312
+3% +$5.54K 0.02% 427
2024
Q3
$198K Buy
10,633
+337
+3% +$6.28K 0.03% 439
2024
Q2
$180K Sell
10,296
-602
-6% -$10.1K 0.03% 433
2024
Q1
$184K Buy
10,898
+154
+1% +$2.62K 0.03% 418
2023
Q4
$178K Buy
+10,744
New +$165K 0.03% 413
2023
Q2
Sell
-10,546
Closed -$186K 438
2023
Q1
$186K Sell
10,546
-582
-5% -$10.6K 0.03% 381
2022
Q4
$200K Buy
11,128
+234
+2% +$4.33K 0.04% 361
2022
Q3
$188K Buy
10,894
+244
+2% +$4.67K 0.05% 340
2022
Q2
$199K Buy
10,650
+237
+2% +$4.69K 0.05% 337
2022
Q1
$216K Buy
10,413
+86
+0.8% +$1.83K 0.04% 366
2021
Q4
$245K Buy
10,327
+191
+2% +$4.76K 0.04% 366
2021
Q3
$259K Sell
10,136
-96
-0.9% -$2.53K 0.05% 346
2021
Q2
$263K Sell
10,232
-926
-8% -$22.8K 0.05% 341
2021
Q1
$272K Buy
11,158
+192
+2% +$4.68K 0.05% 321
2020
Q4
$261K Sell
10,966
-123
-1% -$2.67K 0.06% 311
2020
Q3
$229K Sell
11,089
-3,717
-25% -$78.6K 0.06% 280
2020
Q2
$316K Buy
14,806
+2,723
+23% +$55.5K 0.09% 221
2020
Q1
$215K Sell
12,083
-9
-0.1% -$178 0.08% 239
2019
Q4
$252K Sell
12,092
-1,840
-13% -$36.4K 0.08% 282
2019
Q3
$256K Sell
13,932
-2,005
-13% -$38.6K 0.09% 258
2019
Q2
$320K Sell
15,937
-630
-4% -$12.4K 0.11% 210
2019
Q1
$340K Buy
16,567
+233
+1% +$4.77K 0.12% 202
2018
Q4
$293K Buy
16,334
+194
+1% +$3.97K 0.12% 198
2018
Q3
$374K Buy
16,140
+316
+2% +$7.16K 0.13% 181
2018
Q2
$340K Buy
15,824
+198
+1% +$4.21K 0.13% 193
2018
Q1
$336K Buy
15,626
+321
+2% +$7.39K 0.14% 190
2017
Q4
$345K Buy
15,305
+755
+5% +$17.7K 0.15% 179
2017
Q3
$367K Buy
+14,550
New +$366K 0.16% 162

Other funds holding HQH

Moloney Securities Asset Management's HQH Position: Q3 2025 in Review

Moloney Securities Asset Management increased its abrdn Healthcare Investors (HQH) stake by 3.3% in Q3 2025, buying an estimated $6.37K and bringing the position to 12,080 shares worth $223K. The position accounts for 0.03% of the portfolio, ranked #424.

Moloney Securities Asset Management first reported a position in HQH in Q3 2017 and has held it in 31 quarters since. The position peaked at $374K in Q3 2018. 120 funds tracked by Wall St. Rank hold HQH as of Q3 2025.

  • Moloney Securities Asset Management held 12,080 shares of abrdn Healthcare Investors worth $223K as of Q3 2025.
  • Moloney Securities Asset Management bought 390 abrdn Healthcare Investors shares in Q3 2025, an estimated $6.37K.
  • abrdn Healthcare Investors made up 0.03% of Moloney Securities Asset Management's portfolio in Q3 2025, its #424 holding.
  • Moloney Securities Asset Management first reported a position in abrdn Healthcare Investors in Q3 2017 and has held it in 31 quarters since.
  • Moloney Securities Asset Management's abrdn Healthcare Investors position peaked at $374K in Q3 2018.
  • 120 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.